China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
Classifica tra le azioni
#2914
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent... China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.
Prezzo delle azioni
$3.74
Capitalizzazione di mercato
$6.23B
Variazione (1 giorno)
-2.11%
Variazione (1 anno)
-8.54%
Paese
CN
Scambia China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Categoria
Healthcare
Margine operativo per China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Margine operativo al October 2026 TTM: 14.59%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., il margine operativo attuale (TTM) è 14.59%. Alla fine del 2024, il margine operativo era 16.20%.
Storico del margine operativo per China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. da 2001 a 2026
Margine operativo alla fine di ogni anno
| Anno | Margine Operativo | Cambia |
|---|---|---|
| 2026 (TTM) | 14.59% | -4.95% |
| 2025 | 15.35% | -5.25% |
| 2024 | 16.20% | 6.79% |
| 2023 | 15.17% | -6.93% |
| 2022 | 16.30% | 2.52% |
| 2021 | 15.90% | 4.74% |
| 2020 | 15.18% | -10.71% |
| 2019 | 17.00% | 33.96% |
| 2018 | 12.69% | -6.55% |
| 2017 | 13.58% | -4.90% |
| 2016 | 14.28% | -21.80% |
| 2015 | 18.26% | 8.18% |
| 2014 | 16.88% | -8.31% |
| 2013 | 18.41% | 1.21% |
| 2012 | 18.19% | 8.47% |
| 2011 | 16.77% | -23.95% |
| 2010 | 22.05% | 20.89% |
| 2009 | 18.24% | 24.00% |
| 2008 | 14.71% | 53.55% |
| 2007 | 9.58% | 6.44% |
| 2006 | 9.00% | 38.25% |
| 2005 | 6.51% | -124.66% |
| 2004 | -26.40% | -352.39% |
| 2003 | 10.46% | 22.05% |
| 2002 | 8.57% | 26.22% |
| 2001 | 6.79% | 0.00% |
Margine operativo per aziende simili o concorrenti
| Azienda | Margine Operativo | Differenza del margine operativo | Il paese |
|---|---|---|---|
| 19.41% | -98.67% |
DE
|
|
| 19.68% | -98.65% |
DE
|
|
| 10.52% | -99.28% |
JP
|
|
| 17.08% | -98.83% |
CH
|
|
| 22.93% | -98.43% |
IN
|
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.